Bitdeer Technologies
BTDR
BTCS Inc
BTCS
Bit Digital
BTBT
DMG BLOCKCHAIN SOLUTIONS INC
DMGGF
BIT Mining
BTCM
US Stock MarketDetailed Quotes
FBRX Forte Biosciences
- 22.700
- -1.300-5.42%
Trading Dec 4 15:51 ET
33.19MMarket Cap-1385P/E (TTM)
23.096High20.420Low187.46KVolume20.510Open24.000Pre Close4.13MTurnover20.91%Turnover RatioLossP/E (Static)1.46MShares24.35152wk High3.54P/B20.35MFloat Cap4.11052wk Low--Dividend TTM896.39KShs Float6732.375Historical High--Div YieldTTM11.15%Amplitude4.110Historical Low22.004Avg Price1Lot Size
About Forte Biosciences Company
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.
Company Profile
SymbolFBRX
Company NameForte Biosciences
Listing DateApr 13, 2017
Issue Price10.00
Founded2017
CEODr. Paul A. Wagner, PhD
MarketNASDAQ
Employees9
Fiscal Year Ends12-31
Address3060 Pegasus Park Drive,Building 6
CityDallas
ProvinceTexas
CountryUnited States of America
Zip Code75247
Phone1-310-618-6994
Websitehttp://www.fortebiorx.com
Company Executives
- Name
- Position
- Salary
- Dr. Paul A. Wagner, PhD
- Chairman of the Board, President and Chief Executive Officer
- 1.45M
- Antony A. Riley
- Chief Financial Officer
- 722.98K
- Dr. Barbara K. Finck, M.D.
- Director
- 61.73K
- Dr. Scott C. Brun, M.D.
- Independent Director
- 62.73K
- Steven Kornfeld
- Independent Director
- 97.73K
- Donald A. Williams
- Independent Director
- 85.73K
- David W. Gryska, M.B.A.
- Independent Director
- 104.30K
- Dr. Lawrence Eichenfield, M.D.
- Independent Director
- 62.73K
- Dr. Stephen K. Doberstein, PhD
- Independent Director
- 62.73K